ESG and Sustainability Report

Overview

The report highlights Fosun Pharma's RMB5,937 million in 2023 R&D expenditure and its work to improve access to innovative medicines. The company purchased 14,699,769 kWh of green electricity and reported total waste of 56,029 tons. It also describes Group-wide programs spanning employee development, climate action, and environmental management.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Publication date: 26 March 2024
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services